Cover Image
市場調查報告書

旅行疫苗的全球市場:2015年∼2019年

Global Travel Vaccines Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 325833
出版日期 內容資訊 英文 60 Pages
訂單完成後即時交付
價格
Back to Top
旅行疫苗的全球市場:2015年∼2019年 Global Travel Vaccines Market 2016-2020
出版日期: 2016年11月24日 內容資訊: 英文 60 Pages
簡介

旅行疫苗的全球市場,預計從2014年到2019年的期間,以7.78%的年複合成長率成長。

本報告提供旅行疫苗的全球市場的現狀與成長預測、市場的規模與今後的成長預測、市場成長因素與課題、主要供應商分析等,為您概述為以下內容。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 疫苗的認證流程

第7章 後期階段開發平台候補藥

第8章 市場形勢

  • 市場概要
  • 市場規模、預測
  • 全球A型肝炎疫苗市場
  • 波特的五力分析

第9章 市場區隔:各配方

  • 單價疫苗
    • 多糖類疫苗
    • 共軛疫苗
  • 混合疫苗

第10章 地區區分

第11章 購買標準

第12章 推動市場成長要素

第13章 成長推動因素與其影響

第14章 市場課題

第15章 成長推動因素與課題的影響

第16章 市場趨勢

第17章 趨勢與其影響

第18章 業者情勢

  • 競爭模式
  • 市場佔有率分析
  • 其他有潛力的供應商

第19章 主要供應商分析

  • GlaxoSmithKline
  • Merck
  • Novartis
  • Sanofi

第20章 相關報告

圖表清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR10903

About Travel Vaccines

As the world continues to move toward globalization, the international travels will keep increasing. This fuels the demand for travel vaccines as the prevalence of infectious diseases are specifically region prone, unlike that of other indications. As vaccines are largely used as a preventive measure against these known infectious diseases, the travelers are advised to follow the region-specific immunization plan. The market is growing because various government bodies have mandated the immunization of travelers visiting the infectious-prone areas with various types of vaccines. This, in turn, prevents the spread of infection and averts any chances of epidemic outbreaks.

Technavio's analysts forecast the global travel vaccines market to grow at a CAGR of 6.83% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global travel vaccines market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various vaccines administered to actively immunize meningococcal disease, Japanese encephalitis, rabies, typhoid, yellow fever, hepatitis B, and hepatitis A. The report also considers the revenues to be generated from the sales of vaccines that are expected to be launched into the market during the forecast period.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Travel Vaccines Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • GlaxoSmithKline
  • Merck
  • Pfizer
  • Sanofi

Other Prominent Vendors

  • Abbott
  • AstraZeneca
  • Bavarian Nordic
  • Baxter
  • Beijing Minhai Biotechnology
  • Bharat Biotech
  • Bharat Immunologicals and Biologicals
  • Bio-Med
  • Seqirus CSL
  • Crucell
  • CSL
  • Dynavax Technologies
  • Emergent BioSolutions
  • GlycoVaxyn
  • GreenSignal Bio Pharma
  • Hualan Biological Engineering
  • Imunoloski Zavod
  • Indian Immunologicals
  • Janssen Pharmaceuticals
  • JN International Medical
  • Kaketsuken
  • LG Life Sciences
  • Lupin
  • Mitsubishi Tanabe Pharma
  • Novavax
  • Nuron Biotech
  • Panacea Biotec
  • Pfizer
  • Protein Sciences
  • Roche
  • SK Chemicals
  • Serum Institute of India
  • Shenzhen Kangtai Biological Products
  • Sinovac Biotech
  • Takeda Pharmaceutical
  • Vacunas Finlay
  • Valeant Pharmaceuticals
  • Valneva,
  • Zydus Cadila

Market driver

  • Growing demand among travelers
  • For a full, detailed list, view our report

Market challenge

  • Requires specific storage and distribution system
  • For a full, detailed list, view our report

Market trend

  • Combination vaccines
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Regulatory scenario of vaccines

PART 06: Market landscape

  • Market overview
  • Five forces analysis

PART 07: Market segmentation by disease type

PART 08: Market segmentation by composition

  • Mono vaccines
  • Combination vaccines

PART 09: Geographical segmentation

  • Travel vaccines market in Americas
  • Travel vaccines market in EMEA
  • Travel vaccines market in APAC

PART 10: Market drivers

  • Growing demand among travelers
  • Additional age group approval
  • Inclusion in NIP

PART 11: Impact of drivers

PART 12: Market challenges

  • Requires specific storage and distribution system
  • High risk and cost involved in vaccine development
  • Stringent regulatory guidelines

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Combination vaccines
  • Increase in R&D activities
  • Public-private initiatives

PART 15: Vendor landscape

  • Competitive scenario
  • Other prominent vendors

PART 16: Key vendor analysis

  • GlaxoSmithKline
  • Merck
  • Pfizer
  • Sanofi

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Market share of travel vaccines markets in global pharmaceutical market 2015
  • Exhibit 03: Market share of travel vaccines markets in global pharmaceutical market, 2015
  • Exhibit 04: Country/region-specific vaccination
  • Exhibit 05: Key buying criteria for travel vaccines 2015
  • Exhibit 06: Impact of key customer segments on market 2015
  • Exhibit 07: Requirements for a BLA submission
  • Exhibit 08: Stages of vaccine development to obtain license
  • Exhibit 09: Processes involved in the vaccine development
  • Exhibit 10: Regulatory testing of licensed vaccines
  • Exhibit 11: Market snapshot: Global travel vaccines market
  • Exhibit 12: Worldwide endemicity of HAV infection
  • Exhibit 13: Endemicity pattern of HBV across various regions
  • Exhibit 14: Global travel vaccine market snapshot: Developed and emerging markets 2015
  • Exhibit 15: Overview of vaccine-related acquisitions (2005-2012)
  • Exhibit 16: Global travel vaccines market 2015-2020 ($ billions)
  • Exhibit 17: Few of approved travel vaccines
  • Exhibit 18: Vaccine recommendation for travelers
  • Exhibit 19: Five forces analysis
  • Exhibit 20: Market segmentation of travel vaccines based on disease type 2015
  • Exhibit 21: Market share of the different types of travel vaccines based on disease type 2015
  • Exhibit 22: Overview of global travel vaccines market segmentation based on disease type 2015-2020
  • Exhibit 23: Global travel vaccines market segmentation by composition
  • Exhibit 24: Details of approved polysaccharide vaccines
  • Exhibit 25: Snapshot of global travel vaccines market by geography 2015-2020
  • Exhibit 26: Global travel vaccines market segmentation by geography 2015-2020 ($ millions)
  • Exhibit 27: Overview of travel vaccines market in Americas
  • Exhibit 28: Recommended vaccination for travelers to Mexico
  • Exhibit 29: Recommended vaccination for travelers to Brazil
  • Exhibit 30: Travel vaccines market in Americas 2015-2020 ($ billions)
  • Exhibit 31: Overview of travel vaccines market in EMEA
  • Exhibit 32: Outbreaks of measles in EMEA during 2011
  • Exhibit 33: Recommended vaccination for travelers to Italy
  • Exhibit 34: Recommended vaccinations for travelers to France
  • Exhibit 35: Recommended vaccinations for some travelers to South Africa
  • Exhibit 36: Travel vaccines market in EMEA 2015-2020 ($ millions)
  • Exhibit 37: Overview of travel vaccines market in APAC
  • Exhibit 38: Recommended vaccination for travelers to India
  • Exhibit 39: Recommended vaccination for travelers to China
  • Exhibit 40: Travel vaccines market in APAC 2015-2020 ($ millions)
  • Exhibit 41: Impact of drivers and challenges on global travel vaccines market
  • Exhibit 42: Impact of drivers
  • Exhibit 43: A typical cold chain process
  • Exhibit 44: Impact of drivers and challenges
  • Exhibit 45: Impact of trends on global travel vaccines market
  • Exhibit 46: Competitive structure analysis of global travel vaccines market 2015
  • Exhibit 47: Key vendors: Geographical presence 2015
  • Exhibit 48: Competitive assessment of vendors
  • Exhibit 49: GlaxoSmithKline: Key highlights
  • Exhibit 50: GlaxoSmithKline: Strength assessment
  • Exhibit 51: GlaxoSmithKline: Strategy assessment
  • Exhibit 52: GlaxoSmithKline: Opportunity assessment
  • Exhibit 53: Merck: Key highlights
  • Exhibit 54: Merck: Strength assessment
  • Exhibit 55: Merck: Strategy assessment
  • Exhibit 56: Merck: Opportunity assessment
  • Exhibit 57: Pfizer: Key highlights
  • Exhibit 58: Pfizer: Strength assessment
  • Exhibit 59: Pfizer: Strategy assessment
  • Exhibit 60: Pfizer: Opportunity assessment
  • Exhibit 61: Sanofi: Key highlights
  • Exhibit 62: Sanofi: Strength assessment
  • Exhibit 63: Sanofi: Strategy assessment
  • Exhibit 64: Sanofi: Opportunity assessment
Back to Top